Single Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of BDM-2 in Healthy Male Subjects.
Clinical trial NCT03634085 · COMPLETED
Trial details
- NCT number
- NCT03634085
- Sponsor
- Hivih
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-17
- Primary completion
- 2018-08-13
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.